Virios Therapeutics, Inc.

VIRI · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$12,350-$5-$12-$16
Dep. & Amort.$71$0$0$0
Deferred Tax-$1$0$0$0
Stock-Based Comp.$476$1$1$0
Change in WC$0-$0$0-$0
Other Non-Cash$3,013$0$0$0
Operating Cash Flow-$8,791-$5-$11-$16
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$3,762$0$0$0
Investing Cash Flow$3,762$0$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$1,382$1$4$0
Stock Repurch.$0$0$0-$0
Dividends Paid-$514$0$0$0
Other Fin. Act.$17,219$0$0$0
Financing Cash Flow$16,704$1$4-$0
Forex Effect$0$0$0$0
Net Chg. in Cash$11,531-$4-$7-$16
Supplemental Information
Beg. Cash$3,317$7$14$30
End Cash$14,848$3$7$14
Free Cash Flow-$8,791-$5-$11-$16